Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Value
Increase
Decrease
Funds Holding
5,180
Funds Holding Change
-40
Funds Holding Growth
-0.8%
Value
$1.42T
Holding in Top 10
833
Top 10 Change
-67
Top 10 Growth
-7%
Value Growth
-4%
New
166
Increased
2,284
Reduced
2,397
Closed
139
Capital Inflow
$44.1B
Capital Outflow
$31.8B
Net Capital Flow
+$12.3B
Capital Flow Change
+$13B
Calls
$17.8B
Puts
$17.2B
Net Calls
+$589M
Put/Call Ratio
0.97